316
Views
0
CrossRef citations to date
0
Altmetric
Article

Platelet-endothelial associations may promote cytomegalovirus replication in the salivary gland in mice

ORCID Icon, , , , , , , , , , , , , , & show all
Pages 860-868 | Received 13 Sep 2019, Accepted 31 Oct 2019, Published online: 14 Nov 2019

References

  • Beck SE, Queen SE, Witwer KW, Metcalf Pate KA, Mangus LM, Gama L, Adams RJ, Clements JE, Christine ZM, Mankowski JL. Paving the path to HIV neurotherapy: predicting SIV CNS disease. Eur J Pharmacol 2015;759:303–312. Epub 2015/ 03/31. doi: 10.1016/j.ejphar.2015.03.018
  • Bender BS, Quinn TC, Spivak JL. Homosexual men with thrombocytopenia have impaired reticuloendothelial system Fc receptor-specific clearance. Blood 1987;70:392–395. Epub 1987/ 08/01. doi: 10.1182/blood.V70.2.392.392
  • Deressa T, Damtie D, Workineh M, Genetu M, Melku M. Anemia and thrombocytopenia in the cohort of HIV-infected adults in northwest Ethiopia: a facility-based cross-sectional study. Ejifcc 2018;29:36–47. Epub 2018/ 05/17.
  • Harbol AW, Liesveld JL, Simpson-Haidaris PJ, Abboud CN. Mechanisms of cytopenia in human immunodeficiency virus infection. Blood Rev 1994;8:241–251. Epub 1994/ 12/01. doi: 10.1016/0268-960X(94)90112-0
  • Ragin AB, D’Souza G, Reynolds S, Miller E, Sacktor N, Selnes OA, Martin E, Visscher BR, Becker JT. Platelet decline as a predictor of brain injury in HIV infection. J Neurovirol 2011;17:487–495. Epub 2011/ 10/01. doi: 10.1007/s13365-011-0053-2
  • Wachtman LM, Tarwater PM, Queen SE, Adams RJ, Mankowski JL. Platelet decline: an early predictive hematologic marker of simian immunodeficiency virus central nervous system disease. J Neurovirol 2006;12:25–33. Epub 2006/ 04/06. doi: 10.1080/13550280500516484
  • Dahal S, Upadhyay S, Banjade R, Dhakal P, Khanal N, Bhatt VR. Thrombocytopenia in patients with chronic hepatitis C virus infection. Mediterr J Hematol Infect Dis 2017;9:e2017019. doi: 10.4084/mjhid.2017.019
  • Assinger A. Platelets and infection – an emerging role of platelets in viral infection. Front Immunol 2014;5:649. doi: 10.3389/fimmu.2014.00649
  • Hottz ED, Medeiros-de-Moraes IM, Vieira-de-Abreu A, de Assis EF, Vals-de-Souza R, Castro-Faria-Neto HC, Weyrich AS, Zimmerman GA, Bozza FA, Bozza PT. Platelet activation and apoptosis modulate monocyte inflammatory responses in dengue. J Immunol (Baltimore, Md: 1950) 2014;193:1864–1872. Epub 2014/ 07/13. doi: 10.4049/jimmunol.1400091
  • Osborn JE, Shahidi NT. Thrombocytopenia in murine cytomegalovirus infection. Pediatr Res 1971;5:409. doi: 10.1203/00006450-197108000-00160
  • Rahbar A, Soderberg-Naucler C. Human cytomegalovirus infection of endothelial cells triggers platelet adhesion and aggregation. J Virol 2005;79:2211–2220. Epub 2005/ 02/01. doi: 10.1128/JVI.79.4.2211-2220.2005
  • Assinger A, Kral JB, Yaiw KC, Schrottmaier WC, Kurzejamska E, Wang Y, Mohammad AA, Religa P, Rahbar A, Schabbauer G, et al. Human cytomegalovirus-platelet interaction triggers toll-like receptor 2-dependent proinflammatory and proangiogenic responses. Arterioscler Thromb Vasc Biol 2014;34:801–809. Epub 2014/ 02/22. doi: 10.1161/ATVBAHA.114.303287
  • Guo L, Rondina MT. The era of thromboinflammation: platelets are dynamic sensors and effector cells during infectious diseases. Front Immunol 2019;10:2204. Epub 2019/ 10/02. doi: 10.3389/fimmu.2019.02204
  • Eriksson O, Mohlin C, Nilsson B, Ekdahl KN. The human platelet as an innate immune cell: interactions between activated platelets and the complement system. Front Immunol 2019;10:1590. Epub 2019/ 07/30. doi: 10.3389/fimmu.2019.01590
  • Gaertner F, Massberg S. Patrolling the vascular borders: platelets in immunity to infection and cancer. Nat Rev Immunol 2019. Epub 2019/ 08/15. doi: 10.1038/s41577-019-0202-z.
  • Singh MV, Davidson DC, Kiebala M, Maggirwar SB. Detection of circulating platelet-monocyte complexes in persons infected with human immunodeficiency virus type-1. J Virol Methods 2012;181:170–176. Epub 2012/ 03/06. doi: 10.1016/j.jviromet.2012.02.005
  • da Costa Martins P, Garcia-Vallejo JJ, van Thienen JV, Fernandez-Borja M, van Gils JM, Beckers C, Horrevoets AJ, Hordijk PL, Zwaginga JJ. P-selectin glycoprotein ligand-1 is expressed on endothelial cells and mediates monocyte adhesion to activated endothelium. Arterioscler Thromb Vasc Biol 2007;27:1023–1029. Epub 2007/ 02/27. doi: 10.1161/ATVBAHA.107.140442
  • da Costa Martins PA, van Gils JM, Mol A, Hordijk PL, Zwaginga JJ. Platelet binding to monocytes increases the adhesive properties of monocytes by up-regulating the expression and functionality of beta1 and beta2 integrins. J Leukoc Biol 2006;79:499–507. Epub 2006/ 01/18. doi: 10.1189/jlb.0605318
  • Hecker M, Qiu D, Marquardt K, Bein G, Hackstein H. Continuous cytomegalovirus seroconversion in a large group of healthy blood donors. Vox Sang 2004;86:41–44. Epub 2004/ 02/27. doi: 10.1111/vox.2004.86.issue-1
  • Cytomegalovirus (CMV) and Congenital CMV Infection. The centers for disease control and prevention. Available from: https://www.cdc.gov/cmv/overview.html
  • Britt W, Alford C. Cytomegalovirus. In: Fields B, Knipe D, Howley P, Chanock R, Melnick J, Monath T, Roizman B, Straus S, editors. Fields Virology. 3rd. Philadelphia: Lippincott–Raven Publishers; 1996. p. 2493–2523.
  • EM J. Betaherpes viral genes and their functions. In: Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, Whitley R, Yamanishi K, editors. Human herpesviruses: biology, therapy, and immunoprophylaxis. Cambridge: Cambridge University Press; 2007.Chapter 15.
  • Sinclair J, Sissons P. Latency and reactivation of human cytomegalovirus. J Gen Virol 2006;87:1763–1779. Epub 2006/ 06/09. doi: 10.1099/vir.0.81891-0
  • Ibanez CE, Schrier R, Ghazal P, Wiley C, Nelson JA. Human cytomegalovirus productively infects primary differentiated macrophages. J Virol 1991;65:6581–6588. Epub 1991/ 12/01.
  • Vanarsdall AL, Pritchard SR, Wisner TW, Liu J, Jardetzky TS, Johnson DC. CD147 promotes entry of pentamer-expressing human cytomegalovirus into epithelial and endothelial cells. mBio 2018;9(3). Epub 2018/ 05/10.doi: 10.1128/mBio.00781-18.
  • Mocarski E. Cytomegaloviruses and their replication. In: Fields B, Knipe D, Howley P, Chanock R, Melnick J, Monath T, Roizman B, Straus S, editors. Fields Virology. 3rd. Philadelphia: Lippincott-Raven; 1996. p. 2447–2492.
  • Davison AJ, Bhella D. Comparative genome and virion structure. In: Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, Whitley R, Yamanishi K, editors. Human herpesviruses: biology, therapy, and immunoprophylaxis. Cambridge: Cambridge University Press; 2007.Chapter 14.
  • Kercher L, Mitchell BM. Persisting murine cytomegalovirus can reactivate and has unique transcriptional activity in ocular tissue. J Virol 2002;76:9165–9175. Epub 2002/ 08/21. doi: 10.1128/JVI.76.18.9165-9175.2002
  • Reddehase MJ, Lemmermann NAW. Mouse model of cytomegalovirus disease and immunotherapy in the immunocompromised host: predictions for medical translation that survived the “test of time”.. Viruses 2018;10(12). Epub 2018/ 12/20.doi: 10.3390/v10120693.
  • Slavuljica I, Kvestak D, Huszthy PC, Kosmac K, Britt WJ, Jonjic S. Immunobiology of congenital cytomegalovirus infection of the central nervous system-the murine cytomegalovirus model. Cell Mol Immunol 2015;12:180–191. Epub 2014/ 07/22. doi: 10.1038/cmi.2014.51
  • Reddehase MJ, Simon CO, Seckert CK, Lemmermann N, Grzimek NKA. Murine model of cytomegalovirus latency and reactivation. In: Shenk TE, Stinski MF, editors. Human Cytomegalovirus. Berlin, Heidelberg: Springer Berlin Heidelberg; 2008. p. 315–331.
  • Fonseca BL, Brune W, Stahl FR. Cytomegalovirus (CMV) pneumonitis: cell tropism, inflammation, and immunity. Int J Mol Sci 2019;20(16). Epub 2019/ 08/11.
  • JB H. The murine cytomegalovirus as a model for the study of viral pathogenesis and persistent infections. Arch Virol 1979;62:1–29. Epub 1979/ 01/01. doi: 10.1007/BF01314900
  • Krmpotic A, Bubic I, Polic B, Lucin P, Jonjic S. Pathogenesis of murine cytomegalovirus infection. Microbes Infect 2003;5:1263–1277. Epub 2003/ 11/19. doi: 10.1016/j.micinf.2003.09.007
  • Balthesen M, Messerle M, Reddehase MJ. Lungs are a major organ site of cytomegalovirus latency and recurrence. J Virol 1993;67:5360–5366. Epub 1993/ 09/01.
  • AK F, Fong J. Mouse salivary gland virus plaque assay on a stable line of mouse embryo cells. J Bacteriol 1964;87:1238–1239. Epub 1964/ 05/01.
  • Matsuzawa H, Shimizu K, Okada K, Ando K, Hashimoto K, Koga Y. Analysis of target organs for the latency of murine cytomegalovirus DNA using specific pathogen free and germfree mice. Arch Virol 1995;140:853–864. Epub 1995/ 01/01. doi: 10.1007/BF01314962
  • JA M, CA W, DH S. Pathogenesis of murine cytomegalovirus infection: identification of infected cells in the spleen during acute and latent infections. J Virol 1988;62:987–997. Epub 1988/ 03/01.
  • AA S, Fitzgerald NA, Simmons A, La Vista AB, Shellam GR. Cmv-1, a genetic locus that controls murine cytomegalovirus replication in the spleen. J Exp Med 1990;171:1469–1483. Epub 1990/ 05/01. doi: 10.1084/jem.171.5.1469
  • Vliegen I, Herngreen S, Grauls G, Bruggeman C, Stassen F. Improved detection and quantification of mouse cytomegalovirus by real-time PCR. Virus Res 2003;98:17–25. Epub 2003/ 11/12. doi: 10.1016/j.virusres.2003.08.009
  • Brune W, Hengel H, Koszinowski UH. A mouse model for cytomegalovirus infection. Curr Protoc Immunol 2001;43(1):19.7.1-19.7.13. Chapter 19: Unit 19.17. Epub 2008/ 04/25.doi: 10.1002/0471142735.im1907s43.
  • Brizic I, Lisnic B, Brune W, Hengel H, Jonjic S. Cytomegalovirus infection: mouse model. Curr Protoc Immunol 2018;e51. Epub 2018/ 07/26. doi: 10.1002/cpim.51
  • KA Z, Moghbeli T, Snyder CM. Resolving the titer of murine cytomegalovirus by plaque assay using the M2-10B4 cell line and a low viscosity overlay. Virol J 2014;11:71. Epub 2014/ 04/20. doi: 10.1186/1743-422X-11-71
  • MJ R, Balthesen M, Rapp M, Jonjic S, Pavic I, Koszinowski UH. The conditions of primary infection define the load of latent viral genome in organs and the risk of recurrent cytomegalovirus disease. J Exp Med 1994;179:185–193. Epub 1994/ 01/01. doi: 10.1084/jem.179.1.185
  • Kurz S, Steffens HP, Mayer A, Harris JR, Reddehase MJ. Latency versus persistence or intermittent recurrences: evidence for a latent state of murine cytomegalovirus in the lungs. J Virol 1997;71:2980–2987. Epub 1997/ 04/01.
  • DM A, Farrell HE, Densley EH, Scalzo AA, Shellam GR, Degli-Esposti MA. NK1.1+ cells and murine cytomegalovirus infection: what happens in situ? J Immunol (Baltimore, Md: 1950) 2001;166:1796–1802. Epub 2001/ 02/13. doi: 10.4049/jimmunol.166.3.1796
  • JA M, Spector DH. Pathogenesis of acute murine cytomegalovirus infection in resistant and susceptible strains of mice. J Virol 1986;57:497–504. Epub 1986/ 02/01.
  • JE A, Shellam GR. Genetic control of murine cytomegalovirus infection: virus titres in resistant and susceptible strains of mice. Arch Virol 1984;81:139–150. Epub 1984/ 01/01. doi: 10.1007/BF01309303
  • JE G, Mackenzie JS, Stanley NF. Influence of H-2 and non-H-2 genes on resistance to murine cytomegalovirus infection. Infect Immun 1981;32:277–286. Epub 1981/ 04/01.
  • Behrens K, Alexander WS. Cytokine control of megakaryopoiesis. Growth Factors (Chur, Switzerland) 2018;36:89–103. Epub 2018/ 10/16.
  • Metcalf PKA, Lyons CE, Dorsey JL, Shirk EN, Queen SE, Adams RJ, Gama L, Morrell CN, Mankowski JL. Platelet activation and platelet-monocyte aggregate formation contribute to decreased platelet count during acute simian immunodeficiency virus infection in pig-tailed macaques. J Infect Dis 2013;208:874–883. Epub 2013/ 07/16. doi: 10.1093/infdis/jit278
  • MR T, Storey RF. The role of platelets in inflammation. Thromb Haemost 2015;114:449–458. Epub 2015/ 08/22. doi: 10.1160/TH14-12-1067
  • Johansson D, Shannon O, Rasmussen M. Platelet and neutrophil responses to Gram positive pathogens in patients with bacteremic infection. PLoS One 2011;6:e26928. Epub 2011/ 12/06. doi: 10.1371/journal.pone.0026928
  • AA A, Srivastava K, Ture S, Field DJ, Morrell CN. Platelet induction of the acute-phase response is protective in murine experimental cerebral malaria. J Immunol (Baltimore, Md: 1950) 2013;190:4685–4691. Epub 2013/ 03/29. doi: 10.4049/jimmunol.1202672
  • Srivastava K, Cockburn IA, Swaim A, Thompson LE, Tripathi A, Fletcher CA, Shirk EM, Sun H, Kowalska MA, Fox-Talbot K, et al. Platelet factor 4 mediates inflammation in experimental cerebral malaria. Cell Host Microbe 2008;4:179–187. doi: 10.1016/j.chom.2008.07.003
  • JJ T, Jen YH, Chang JS, Hsiao HM, Noisakran S, Perng GC. Frequency alterations in key innate immune cell components in the peripheral blood of dengue patients detected by FACS analysis. J Innate Immun 2011;3:530–540. Epub 2011/ 02/22. doi: 10.1159/000322904
  • MT R, Brewster B, Grissom CK, Zimmerman GA, Kastendieck DH, Harris ES, Weyrich AS. In vivo platelet activation in critically ill patients with primary 2009 influenza A(H1N1). Chest 2012;141:1490–1495. Epub 2012/ 03/03. doi: 10.1378/chest.11-2860
  • ED H, Oliveira MF, Nunes PC, Nogueira RM, Valls-de-Souza R, Da Poian AT, Weyrich AS, Zimmerman GA, Bozza PT, Bozza FA. Dengue induces platelet activation, mitochondrial dysfunction and cell death through mechanisms that involve DC-SIGN and caspases. J Thrombosis Haemostasis 2013;11:951–962. Epub 2013/ 02/26. doi: 10.1111/jth.12178
  • DC D, Hirschman MP, Sun A, Singh MV, Kasischke K, Maggirwar SB. Excess soluble CD40L contributes to blood brain barrier permeability in vivo: implications for HIV-associated neurocognitive disorders. PLoS One 2012;7:e51793. Epub 2012/ 12/20. doi: 10.1371/journal.pone.0051793
  • BH H, Fu J, Wilson SJ, Hess PR, Sen A, McDaniel JM, Pan Y, Sheng M, Yago T, Silasi-Mansat R, et al. Podoplanin maintains high endothelial venule integrity by interacting with platelet CLEC-2. Nature 2013;502:105–109. Epub 2013/ 09/03. doi: 10.1038/nature12501
  • Le VB, Schneider JG, Boergeling Y, Berri F, Ducatez M, Guerin JL, Adrian I, Errazuriz-Cerda E, Frasquilho S, Antunes L, et al. Platelet activation and aggregation promote lung inflammation and influenza virus pathogenesis. Am J Respir Crit Care Med 2015;191:804–819. Epub 2015/02/11.
  • EA F, McElroy AK, Sanchez I, Spector DH. Exploitation of cellular signaling and regulatory pathways by human cytomegalovirus. Trends Microbiol 2000;8:111–119. Epub 2000/ 03/09. doi: 10.1016/S0966-842X(00)01699-1
  • GE K, Horvat JC, Beagley KW, Hansbro PM. Immunological decision-making: how does the immune system decide to mount a helper T-cell response? Immunology 2008;123:326–338. doi: 10.1111/j.1365-2567.2007.02719.x
  • BS F-C, Arias-Morales CE, Wadskier FG, Gupta S, Stoicea N. Immune thrombocytopenic purpura secondary to cytomegalovirus infection: a case report. Front Med 2015;2:79. Epub 2015/ 11/19. doi: 10.3389/fmed.2015.00061

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.